Cabotegravir Sodium is an HIV integrase inhibitor (IC50 = 2.5 nM for HIVADA) with anti-HIV activity. Cabotegravir sodium is mainly metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, and exhibits low potential to interact with other antiretroviral drugs (ARVs).

纯度：≥98%

CAS：1051375-13-3